Showing results 109 to 128 of 168
< previous
next >
Issue Date | Title | Type | Author(s) |
2006 | Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma | Articulo | Tirapu, I. (Íñigo); Huarte, E. (Eduardo); Guiducci, C. (Cristiana); Arina, A. (Ainhoa); Zaratiegui, M. (Mikel); Murillo, O. (Oihana); Gonzalez-Hernandez, A. (Alvaro); Berasain, C. (Carmen); Berraondo, P. (Pedro); Fortes, P. (Puri); Prieto, J. (Jesús); Colombo, M.P. (Mario P.); Chen, L. (Lieping); Melero, I. (Ignacio) |
2009 | Lysine 63 polyubiquitination in immunotherapy and in cancer-promoting inflammation | Articulo | Martinez-Forero, I. (Iván); Rouzaut, A. (Ana); Palazon, A. (Asís); Dubrot, J. (Juan); Melero, I. (Ignacio) |
2004 | MAGE antigens: therapeutic targets in hepatocellular carcinoma? | Articulo | Sarobe, P. (Pablo); Feijoo, E. (Esperanza); Alfaro, C. (Carlos); Mazzolini, G. (Guillermo); Melero, I. (Ignacio) |
2015 | Molecular and cellular basis for immunomodulation with monoclonal antibodies | Articulo | Melero, I. (Ignacio) |
2012 | Molecular pathways: hypoxia response in immune cells fighting or promoting cancer | Articulo | Palazon, A. (Asís); Aragones, J. (Julián); Morales-Kastresana, A. (Aizea); Ortiz-de-Landazuri, M. (Manuel); Melero, I. (Ignacio) |
2021 | Mouse Models of Peritoneal Carcinomatosis to Develop Clinical Applications | Revision | Bella-Carreño, Á. (Ángela); Di-Trani, C.A. (Claudia Augusta); Fernández-Sendín, M. (Myriam); Arrizabalaga, L. (Leire); Cirella, A. (Assunta); Teijeira, A. (Álvaro); Medina-Echeverz, J. (José); Melero, I. (Ignacio); Berraondo, P. (Pedro); Aranda, F. (Fernando) |
2023 | mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy | Articulo | Olivera, I. (Irene); Bolaños, E. (Elixabet); González-Gomariz, J. (José); Hervas-Stubbs, S. (Sandra); Mariño, K. (Karina); Luri-Rey, C. (Carlos); Etxeberria, I. (Iñaki); Cirella, A. (Assunta); Egea, J. (Josune); González-Vaz, J. (Javier); Garasa, S. (Saray); Álvarez-Rodríguez, M. (Maite); Eguren-Santamaría, I. (Iñaki); Guedan, S. (Sonia); Fernandez-Sanmamed, M. (Miguel); Berraondo, P. (Pedro); Rabinovich, G.A. (Gabriel A.); Teijeira, A. (Álvaro); Melero, I. (Ignacio) |
2008 | Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies | Articulo | Melero, I. (Ignacio); Murillo, O. (Oihana); Dubrot, J. (Juan); Hervas-Stubbs, S. (Sandra); Perez-Gracia, J.L. (Jose Luis) |
2018 | Neoadjuvant immunotherapy in non-small cell lung cancer: the sooner the better? | Articulo | Perez-Gracia, J.L. (Jose Luis); Fernandez-Sanmamed, M. (Miguel); Melero, I. (Ignacio) |
2019 | Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma | Articulo | Schalper, K.A. (Kurt A.); Rodriguez-Ruiz, M.E. (María Esperanza); Diez-Valle, R. (Ricardo); López-Janeiro, Á. (Álvaro); Porciuncula, A. (Angelo); Idoate, M.A. (Miguel Ángel); Inoges, S. (Susana); Andrea, C.E. (Carlos Eduardo) de; Lopez-Diaz-de-Cerio, A. (Ascensión); Tejada-Solis, S. (Sonia); Berraondo, P. (Pedro); Villarroel-Espindola, F. (Franz); Choi, J. (Jungmin); Gurpide, A. (Alfonso); Giraldez, M. (Miriam); Goicoechea, I. (Iosune); Gallego-Perez-Larraya, J. (Jaime); Fernandez-Sanmamed, M. (Miguel); Perez-Gracia, J.L. (Jose Luis); Melero, I. (Ignacio) |
2019 | New emerging targets in cancer immunotherapy: CD137/4-1BB costimulatory axis | Revision | Etxeberria, I. (Iñaki); González-Vaz, J. (Javier); Teijeira, A. (Álvaro); Melero, I. (Ignacio) |
2007 | New treatments for renal carcinoma | Articulo | Perez-Gracia, J.L. (Jose Luis); Lopez-Picazo, J.M. (José M.); Olier, C. (Clara); Alfaro, C. (Carlos); Garcia-Foncillas, J. (Jesús); Melero, I. (Ignacio); Gurpide, A. (Alfonso) |
2015 | Nivolumab and urelumab enhance antitumor activity of human T lymphocytes engrafted in Rag2-/-IL2Rγnull immunodeficient mice | Articulo | Fernandez-Sanmamed, M. (Miguel); Rodriguez, I. (Inmaculada); Schalper, K.A. (Kurt A.); Oñate, C. (Carmen); Azpilikueta, A. (Arantza); Rodriguez-Ruiz, M.E. (María Esperanza); Morales-Kastresana, A. (Aizea); Labiano, S. (Sara); Perez-Gracia, J.L. (Jose Luis); Martin-Algarra, S. (Salvador); Alfaro, C. (Carlos); Mazzolini, G. (Guillermo); Sarno, F. (Francesca); Hidalgo, M. (Manuel); Korman, A.J. (Alan J.); Jure-Kunkel, M. (María); Melero, I. (Ignacio) |
2023 | Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040 | Articulo | El-Khoueiry, A. (Anthony); Trojan, J. (Jörg); Meyer, T. (Tim); Yau, T. (Thomas); Melero, I. (Ignacio); Kudo, M. (Masatoshi); Hsu, C. (Chiun); Kim, T.Y. (Tae-You); Choo, S.P. (Su-Pin); Kang, Y.K. (Yoon-Koo); Yeo, W. (W.); Chopra, A. (A.); Soleymani, S. (S.); Yao, J. (J.); Neely, J. (Jaclyn); Tschaika, M. (Marina); Welling, T.H. (T. H.); Sangro, B. (Bruno) |
2022 | Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial | Articulo | Yau, T. (Thomas); Park, J.W. (Joong-Won); Finn, R.S. (Richard S.); Cheng, A.L. (Ann-Lii); Mathurin, P. (Philippe); Edeline, J. (Julien); Kudo, M. (Masatoshi); Harding, J.J. (James J.); Merle, P. (Philippe); Rosmorduc, O. (Olivier); Wyrwicz, L. (Lucjan); Schott, E. (Eckart); Choo, S.P. (Su-Pin); Kate-Kelley, R. (Robin); Sieghart, W. (Wolfgang); Assenat, E. (Eric); Zaucha, R. (Renata); Furuse, J. (Junji); Abou-Alfa, G.K. (Ghassan K.); El-Khoueiry, A. (Anthony); Melero, I. (Ignacio); Begic, D. (Damir); Chen, G. (Gong); Neely, J. (Jaclyn); Wisniewski, T. (Tami); Tschaika, M. (Marina); Sangro, B. (Bruno) |
30-Jan-2020 | On mechanisms underlying efficacy and safety in cancer immunotherapy | Tesis | Cordeiro-Minute, L. R (Luna Ridan) |
15-Jul-2019 | On the hipoxia regulation of CD137 and CD69 expression | Tesis | Labiano, S. (Sara) |
2009 | Palettes of vaccines and immunostimulatory monoclonal antibodies for combination | Articulo | Melero, I. (Ignacio); Martinez-Forero, I. (Iván); Dubrot, J. (Juan); Suarez, N. (Natalia); Palazon, A. (Asís); Chen, L. (Lieping) |
2003 | Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis | Articulo | Mazzolini, G. (Guillermo); Narvaiza, I. (Íñigo); Martinez-Cruz, L.A. (L. Alfonso); Arina, A. (Ainhoa); Barajas, M. (Miguel); Galofre, J.C. (Juan Carlos); Qian, C. (Cheng); Mato, J.M. (José María); Prieto, J. (Jesús); Melero, I. (Ignacio) |
2004 | Pasado, presente y futuro de la vacunación anti-idiotipo | Articulo | Rodriguez-Calvillo, M. (Mercedes); Inoges, S. (Susana); Lopez-Diaz-de-Cerio, A. (Ascensión); Zabalegui, N. (Natalia); Panizo, C. (Carlos); Hernandez, M. (Milagros); Perez-Calvo, J. (Javier); Prosper-Cardoso, F. (Felipe); Melero, I. (Ignacio); Sanchez-Ibarrola, A. (Alfonso); Rocha, E. (Eduardo); Bendandi, M. (Maurizio) |